Swiss National Bank - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 72 filers reported holding ITEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$554,070
-17.3%
50,6000.0%0.00%
Q2 2023$669,944
+16.6%
50,600
+19.9%
0.00%
Q1 2023$574,342
-37.7%
42,200
-10.6%
0.00%
-100.0%
Q4 2022$921,816
+5.7%
47,200
+3.1%
0.00%0.0%
Q3 2022$872,000
-7.5%
45,8000.0%0.00%0.0%
Q2 2022$943,000
-12.3%
45,800
+37.1%
0.00%0.0%
Q1 2022$1,075,000
-25.5%
33,400
+7.7%
0.00%0.0%
Q4 2021$1,443,000
+52.4%
31,000
+11.9%
0.00%0.0%
Q1 2021$947,000
+1.1%
27,7000.0%0.00%0.0%
Q4 2020$937,00027,7000.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$37,274,86415.53%
MPM BioImpact LLC 1,745,943$23,762,2846.17%
Saturn V Capital Management LP 480,653$6,541,6874.89%
Boxer Capital, LLC 2,154,058$29,3171.44%
RA Capital Management 4,417,259$60,118,8951.36%
Octagon Capital Advisors LP 596,000$8,111,5601.17%
BVF INC/IL 1,810,835$24,645,4640.90%
AlphaCentric Advisors LLC 63,000$857,4300.59%
Integral Health Asset Management, LLC 180,000$2,449,8000.49%
683 Capital Management, LLC 480,000$6,532,8000.49%
View complete list of ITEOS THERAPEUTICS INC shareholders